Rating History for Corvus Pharmaceuticals (CRVS) by Ladenburg Thalmann
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 7/29/2026 | Kevin DeGeeter | New Coverage | Buy (N/A) |
32.00 (N/A) |
13.31 (14.08) |
5.79% | Details |
 |
|||||||
|
|||||||
|
|||||||
|
|||||||
